Billionaire investor Ray Dalio is shifting focus toward dividend-paying giants as global risks rise. His latest stock picks reveal a strategy built for stability, income, and uncertain times.
A Stark Warning That Is Driving Investment Decisions
Ray Dalio, founder of Bridgewater Associates, has spent over 50 years studying global markets. His recent warning has caught the attention of financial circles.
Speaking in February at the World Governments Summit in Dubai, he said the world is approaching a phase where financial systems could be used as tools of conflict. He described this as a potential capital war where countries may restrict capital flows, impose trade barriers, or use debt strategically.
Dalio linked this risk to historical patterns, including the period before World War II, when economic tensions escalated into broader conflict. He also pointed out that institutions such as central banks and sovereign funds are already preparing for possible disruptions.
This perspective becomes more significant after his transition out of leadership at Bridgewater Associates in August 2025, when he sold his remaining stake and stepped down from the board, while continuing as an investor and mentor.
Why These Dividend Stocks Matter Now
Dalio’s latest portfolio moves show a clear shift toward companies that can generate steady income while operating in essential sectors. His Q4 2025 holdings highlight five major stocks with dividend yields ranging from 2.28% to 4.60%.
These companies span consumer goods, banking, healthcare, and insurance, which are sectors that tend to remain stable even during economic uncertainty.
The J. M. Smucker Company Balances High Yield with Market Concerns
With a stake valued at $22,786,404 and a dividend yield of 4.60% as of April 17, this company offers the highest yield among the five.
On April 14, Barclays reduced its price target to $103 from $125 and maintained an Equal Weight rating, citing rising input costs and concerns about dividend sustainability in the food sector. On the same day, Rob Dickerson initiated coverage with a Buy rating and a $120 target, citing growth potential in the coffee segment and a portfolio aligned with evolving consumer trends.
Procter & Gamble Faces Cost Pressures Despite Global Scale
This holding is valued at $26,562,652 with a dividend yield of 2.96% as of April 17.
On April 17, JPMorgan analyst Andrea Teixeira lowered the price target to $162 from $165 while maintaining an Overweight rating, highlighting focus on consumer behavior and rising costs. Earlier on April 14, Barclays reduced its target to $146 from $155 and maintained an Equal Weight rating due to similar cost-related concerns.
M&T Bank Corporation Shows Strength in Credit and Growth Outlook
The position stands at $31,198,372 with a dividend yield of 2.74% as of April 17.
On April 17, Cantor Fitzgerald analyst Dave Rochester maintained an Overweight rating and revised the price target to $253 from $255, citing strong deposit growth, capital generation, and expected earnings growth. On April 16, DA Davidson raised its target to $235 from $233 after better-than-expected Q1 results. The bank also adjusted its CET1 target range to 10.0%–10.5%, reflecting improved credit trends and continued momentum.
Merck & Co., Inc. Gains with Key Regulatory Approval
This investment is valued at $32,653,862 with a dividend yield of 2.91% as of April 17.
On April 17, the European Commission approved ENFLONSIA, a preventive treatment for respiratory syncytial virus in infants. The therapy protects for up to 5 months and is already approved in markets such as the United States, Canada, and Switzerland. Macaya Douoguih described the approval as a major step toward expanding access and reducing disease burden.
American International Group Anchors the Portfolio with the Largest Allocation
This is the largest holding at $34,019,727 with a dividend yield of 2.28% as of April 17.
On April 14, Bank of America analyst Joshua Shanker lowered the price target to $79 from $80 while maintaining a Neutral rating. On April 13, Mizuho analyst Yaron Kinar lowered the target to $84 from $86 and maintained a similar rating.
The firm is also working to bring its expense ratio below 30% by 2027, with CFO Keith Walsh expressing confidence in meeting these goals.
The Bigger Picture for Investors
The five stocks reflect a consistent approach. Ray Dalio is focusing on companies with stable cash flows and reliable dividends across essential industries.
Dividend yields range from 2.28% to 4.60%, while analyst sentiment shows growing caution about cost pressures and broader economic uncertainty. This combination highlights a balanced strategy that prioritizes income and resilience in a potentially volatile global environment.
